Transtech Optelecom Science Holdings Limited carries a market capitalization of 2.12B, placing it among publicly traded companies globally. Its enterprise value stands at 234.28M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.12B |
| Enterprise Value | 234.28M |
Transtech Optelecom Science Holdings Limited currently has 260.00M shares outstanding.
| Shares Outstanding | 260.00M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Transtech Optelecom Science Holdings Limited trades at a trailing price-to-earnings ratio of 14.03. The price-to-sales ratio is 0.77, and the price-to-book ratio stands at 95.00.
| PE Ratio | 14.03 |
| PS Ratio | 0.77 |
| PB Ratio | 95.00 |
| P/TBV Ratio | 0.36 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Transtech Optelecom Science Holdings Limited trades at an EV/EBITDA multiple of 6.50 and an EV/FCF ratio of 277.63. The EV/Sales ratio of 0.73 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 6.50 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.73 |
| EV / EBITDA | 6.50 |
| EV / EBIT | 6.50 |
| EV / FCF | 277.63 |
Transtech Optelecom Science Holdings Limited maintains a current ratio of 8.84, meaning it holds 8.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 4.27, indicating elevated leverage, while an interest coverage ratio of 33.30 demonstrates strong ability to service its debt obligations.
| Current Ratio | 8.84 |
| Quick Ratio | 0.82 |
| Debt / Equity | 4.27 |
| Debt / EBITDA | 0.81 |
| Interest Coverage | 33.30 |
Transtech Optelecom Science Holdings Limited posts a return on equity of 13.14 and a return on invested capital of 4.01.
| Return on Equity (ROE) | 13.14 |
| Return on Assets (ROA) | 2.36 |
| Return on Invested Capital (ROIC) | 4.01 |
| Return on Capital Employed (ROCE) | 11.50 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 4.05 |
Over the trailing twelve months, Transtech Optelecom Science Holdings Limited has paid 4.99M in income taxes, reflecting an effective tax rate of 22.08.
| Income Tax | 4.99M |
| Effective Tax Rate | 22.08 |
Transtech Optelecom Science Holdings Limited's stock has gained approximately 1894.3662% over the past 52 weeks. The 50-day moving average sits at 4.88, while the 200-day moving average is 1.92.
| Beta (5Y) | N/A |
| 52-Week Price Change | 1894.3662% |
| 50-Day Moving Average | 4.88 |
| 200-Day Moving Average | 1.92 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Transtech Optelecom Science Holdings Limited generated 320.12M in revenue and converted that into 17.61M in net income, yielding earnings per share of 0.07. EBITDA reached 36.07M, while operating income came in at 36.07M.
| Revenue | 320.12M |
| Gross Profit | 63.04M |
| Operating Income | 36.07M |
| Pretax Income | 22.60M |
| Net Income | 17.61M |
| EBITDA | 36.07M |
| EBIT | 36.07M |
| Earnings Per Share (EPS) | 0.07 |
Transtech Optelecom Science Holdings Limited holds 41.78M in cash and equivalents against 29.06M in total debt, resulting in a net debt position of -25.00M. Total book value stands at 2.60M, with working capital of 398.33M providing operational flexibility.
| Cash & Cash Equivalents | 41.78M |
| Total Debt | 29.06M |
| Net Debt | -25.00M |
| Equity (Book Value) | 2.60M |
| Book Value Per Share | 0.01 |
| Working Capital | 398.33M |
Transtech Optelecom Science Holdings Limited operates with a gross margin of 19.69, reflecting its pricing power and cost economics. The operating margin of 11.27 and net profit margin of 5.50 provide insight into operational efficiency.
| Gross Margin | 19.69 |
| Operating Margin | 11.27 |
| Pretax Margin | 7.06 |
| Profit Margin | 5.50 |
| EBITDA Margin | 11.27 |
Transtech Optelecom Science Holdings Limited posts an Altman Z-Score of 3.71, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.71 |